logo image

Qudict from Sun



Qudict Buprenorphine 2 mg, naloxone
0.5 mg.




Qudict SL-TAB



Qudict from Sun contains Buprenorphine

Below are some of the details of Buprenorphine(generic)

Buprenorphine is a semi-synthetic opiate with partial agonist and antagonist actions. Buprenorphine hydrochloride was first marketed in the 1980s by Reckitt & Colman (now Reckitt Benckiser) as an analgesic, available generally as Temgesic 0.2mg sublingual tablets, and as Buprenex in a 0.3mg/ml injectable formulation. In October 2002, the Food and Drug Administration (FDA) of the United States of America additionally approved Suboxone and Subutex, buprenorphine's high-dose sublingual pill preparations for opioid addiction, and as such the drug is now also used for this purpose. In the European Union, Suboxone and Subutex, buprenorphine's high-dose sublingual pill preparations were approved for opioid addiction treatment in September 2006. In the Netherlands, Buprenorphine is a List II drug of the Opium Law, though special rules and guidelines apply to its prescription and dispensation. In the USA, it has been a Schedule III drug under the United Nations' Convention on Psychotropic Substances since it was rescheduled from Schedule V just before FDA approval of Suboxone and Subutex.[1] In recent years, buprenorphine has been introduced in most European countries as a transdermal formulation for the treatment of chronic pain.

More vital info on Qudict’s generic

© 2011-2018 DrugsUpdate.com. Disclaimer | Site Map